Recorded Presentations from the NCCN 2025 Annual Conference

The NCCN 2025 Annual Conference addressed timely and important educational needs of cancer care providers to improve and facilitate quality, effective, equitable and accessible cancer care so patients can live better lives.

The conference focuses on the practical management of patients living with or at risk for cancer, provides updates of NCCN Guidelines, and includes educational sessions on new treatments, therapies, and trends, and their application in patient care. The conference also provides a venue for education around best practices for cancer care delivery.

Target Audience

This program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, PAs, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

The goal of NCCN continuing education is to change patient outcomes by improving the competence and performance of clinicians. The goal of the NCCN 2025 Annual Conference is to ensure that members of the interprofessional oncology care team have the knowledge and skills necessary to:

  • Apply the current recommendations for oncology care and key updates in the NCCN Guidelines to optimize the management of patients with cancer.
  • Evaluate new, emerging, and novel therapeutic agents, treatment strategies, and clinical trials data and apply relevant findings into the management of patients with cancer.
  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with cancer and the delivery of oncology care.
Additional information
Supporters: 

Supported by educational grants from AstraZeneca; BeiGene; Coherus BioSciences; Eisai, Inc.; Exact Sciences; Ferring Pharmaceuticals; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Lantheus; Lilly; Menarini-Stemline; Novartis; Novocure; Pharmacosmos Therapeutics Inc.; Puma Biotechnology; and Taiho Oncology, Inc. Supported by independent medical education grants from AbbVie; ADC Therapeutics; Boehringer Ingelheim Pharmaceuticals, Inc.; GSK; Jazz Pharmaceuticals; and Rigel Pharmaceuticals, Inc. Supported by independent educational grants from Daiichi Sankyo; Incyte Corporation; and Merck & Co., Inc., Rahway, NJ, USA. This activity is supported by funding from Blue Earth Diagnostics, A Bracco Company. This educational activity is supported by a medical education grant from Exelixis, Inc. This project has been made possible in part by a grant from Varian Medical Systems, a Siemens Healthineers company/Global Medical Education Grant Program.

Course summary
Course opens: 
06/15/2025
Course expires: 
03/01/2026
Cost:
$0.00

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions 

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Click here to download the faculty disclosures for this program.

This program has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, PAs, pharmacists, and other health care professionals. Complete accreditation information is provided before each individual educational activity.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing